2019

1. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study

   The journal of prevention of Alzheimer's disease, Vol. 6, Núm. 1, pp. 34-41

2. Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: A cross-sectional analysis from the AB255 Study

   Alzheimer's Research and Therapy, Vol. 11, Núm. 1